Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Receivables - Net (2016 - 2026)

Cytosorbents filings provide 15 years of Receivables - Net readings, the most recent being $7.6 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 3.14% to $7.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.6 million, a 3.14% increase, with the full-year FY2025 number at $7.6 million, up 3.14% from a year prior.
  • Receivables - Net hit $7.6 million in Q4 2025 for Cytosorbents, up from $7.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $7.8 million in Q2 2024 to a low of $4.5 million in Q4 2021.
  • Median Receivables - Net over the past 5 years was $6.1 million (2023), compared with a mean of $6.2 million.
  • The widest YoY moves for Receivables - Net: up 47.92% in 2021, down 12.32% in 2021.
  • Cytosorbents' Receivables - Net stood at $4.5 million in 2021, then grew by 25.24% to $5.7 million in 2022, then grew by 6.92% to $6.1 million in 2023, then increased by 20.85% to $7.3 million in 2024, then rose by 3.14% to $7.6 million in 2025.
  • The last three reported values for Receivables - Net were $7.6 million (Q4 2025), $7.4 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.